Ticker	Volume	Price	Price Delta
DJIA	15,377.10	+22.66	0.15%
S&P 500	1,672.65	+5.18	0.31%
Nasdaq	3,503.38	+4.41	0.13%

Ticker

Volume

Price

Price Delta

DJIA

15,377.10

+22.66

0.15%

S&P 500

1,672.65

+5.18

0.31%

Nasdaq

3,503.38

+4.41

0.13%

Ticker	Volume	Price	Price Delta
STOXX 50	2,824.50	+6.51	0.23%
FTSE 100	6,755.63	+32.57	0.48%
DAX	8,455.83	+57.83	0.69%

Ticker

Volume

Price

Price Delta

STOXX 50

2,824.50

+6.51

0.23%

FTSE 100

6,755.63

+32.57

0.48%

DAX

8,455.83

+57.83

0.69%

Ticker	Volume	Price	Price Delta
Nikkei	15,360.80	+222.69	1.47%
Hang Seng	23,493.00	+410.35	1.78%
S&P/ASX 200	5,209.04	+28.26	0.55%

Ticker

Volume

Price

Price Delta

Nikkei

15,360.80

+222.69

1.47%

Hang Seng

23,493.00

+410.35

1.78%

S&P/ASX 200

5,209.04

+28.26

0.55%

Capital Impact: Health Spending and Lame-Duck Congress (Audio)

2012-10-03T13:56:01Z

Matt Barry, a Bloomberg Government health-care analyst, explains how a deficit deal involving Medicare and Medicaid may affect health providers. Christopher Payne, a Bloomberg Government economic analyst, discusses why capital buffers for Money Market Funds are not as costly as predicted. Congressional analyst Loren Duggan explains what may happen during Congress' lame-duck session. They talk with Allen Scott on "Bloomberg Government's Capital Impact." (Source: Bloomberg)

Running time 23:21

Audio Download: Health Spending and Lame-Duck Congress

More News:

Bloomberg Government's Capital Impact

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.